Aloran Mazumder
Aloran Mazumder
Sanford Burnham Prebys Medical Discovery Institute
Patvirtintas el. paštas
4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer
C Seidel, M Schnekenburger, A Mazumder, MH Teiten, G Kirsch, M Dicato, ...
Biochemical pharmacology 99, 31-52, 2016
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in …
C Florean, M Schnekenburger, JY Lee, KR Kim, A Mazumder, S Song, ...
Oncotarget 7 (17), 24027, 2016
Natural scaffolds in anticancer therapy and precision medicine
A Mazumder, C Cerella, M Diederich
Biotechnology advances 36 (6), 1563-1585, 2018
Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death
NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A De Carvalho, ...
Frontiers in pharmacology 9, 70, 2018
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ...
Cancer letters 438, 197-218, 2018
Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia
C Cerella, A Gaigneaux, A Mazumder, JY Lee, E Saland, F Radogna, ...
Leukemia 31 (3), 755-759, 2017
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
S Song, JY Lee, L Ermolenko, A Mazumder, S Ji, H Ryu, HJ Kim, DW Kim, ...
Cell death & disease 11 (2), 109, 2020
Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New …
M Schnekenburger, E Goffin, JY Lee, JY Jang, A Mazumder, S Ji, ...
Journal of medicinal chemistry 60 (11), 4714-4733, 2017
Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer
EY Efe, A Mazumder, JY Lee, A Gaigneaux, F Radogna, MJ Nasim, ...
Cancer Letters 410, 139-157, 2017
The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer
S Ji, JY Lee, J Schrör, A Mazumder, DM Jang, S Chateauvieux, ...
Cancer letters 416, 109-123, 2018
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
M Lernoux, M Schnekenburger, H Losson, K Vermeulen, H Hahn, ...
Clinical Epigenetics 12, 1-26, 2020
HER2 activation and endocrine treatment resistance in HER2-negative breast cancer
A Mazumder, S Shiao, S Haricharan
Endocrinology 162 (10), bqab153, 2021
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ...
Nature communications 12 (1), 2940, 2021
Preclinical assessment of the bioactivity of the anticancer coumarin OT48 by spheroids, colony formation assays, and zebrafish xenografts
JY Lee, A Mazumder, M Diederich
JoVE (Journal of Visualized Experiments), e57490, 2018
The DNA damage repair landscape in Black women with breast cancer
A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ...
Therapeutic advances in medical oncology 14, 17588359221075458, 2022
Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells
C Grandjenette, M Schnekenburger, A Gaigneaux, D Gerard, C Christov, ...
Cancer Letters 469, 468-480, 2020
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia
H Losson, SR Gajulapalli, M Lernoux, JY Lee, A Mazumder, D Gérard, ...
Pharmacological Research 160, 105058, 2020
Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death. Front Pharmacol 9: 70–70
NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A de Carvalho, ...
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness
E Oropeza, S Seker, S Carrel, A Mazumder, D Lozano, A Jimenez, ...
Science Advances 9 (26), eadf2860, 2023
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome
MN Bainbridge, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ...
Brain 145 (10), 3383-3390, 2022
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20